Analysis of human serum from women affected by cervical lesions

Journal of Experimental Therapeutics and Oncology

Volumn 7, Issue 1, 2008, Pages 65-72

  De La Rosa, Ana P Barba ^a   Lugo Melchor, Ofelia Y ^a   Briones Cerecero, Erika P ^a   Chagolla López, Alicia ^b   De León Rodríguez, Antonio ^a   Santos, Leticia ^a   Vázquez Ortíz, Guelaguetza ^c   Salcedo, Mauricio ^c  

^a INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

^b DEPARTAMENTO DE INGENIERÍA GENÉTICA   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Biomarkers; MALDI TOF; Metalloproteinases; Plasma_Human Map; Two dimensional electrophoresis; Western blot

Indexed keywords

APOLIPOPROTEIN; HAPTOGLOBIN; METALLOPROTEINASE; PREALBUMIN; PROTEOME;

ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MEXICO; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; UTERINE CERVIX CANCER; WESTERN BLOTTING;

APOLIPOPROTEINS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HAPTOGLOBINS; HUMANS; METALLOPROTEASES; NEOPLASM INVASIVENESS; PREALBUMIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 42149110868     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Pollack AE, Balkin MS, Denny L. Cervical cancer: a call for political will. Int J Gynecol Obs 94:333-342, 2006.
2. Walboomers J, Jacogs M, Manos M, et al. Human papilloma virus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19, 1999.
3. Lin YW, Lai HC, Lin CY, et al. Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix. Int J Gynecol Cancer 16:12161224, 2006.
4. Chromy BA, Gonzales AD, Perkins et al. Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins. Proteome Res 3:1120-1127, 2004.
5. Gadducci A, Cosio S, Carpi A, et al. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother 58:24-38, 2004.
6. Ren Y, He Q, Fan J, et al. The use of proteomics in the discovery of serum biomarkers from patients with sever acute respiratory syndrome. Proteomics 4:3477-3484, 2004.
7. Anderson NL, Anderson NG. The human plasma proteome. Mol Cell Proteomics 1:845-867, 2002.
8. Jacobs JM, Adkins JN, Quian WJ, et al. Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res 4:1073-1085, 2005.
9. Villanueva J, Philip J, Chapparo CA, et al. Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res 14:1060-1072, 2005.
10. Selliger B, Kellner R. Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets. Proteomics 2:1641-1651, 2002.
11. Caron M, Choquet-Kastylevsky G, Joubert-Caron R. Cancer immunomics using autoantibody signatures for biomarker discovery. Mol Cell Protomics 6:1115-1122, 2007.
12. Zhang RL, Barker L, Pinchev D, et al. Mining biomarkers in human sera using proteomic tools. Proteomics 4:244-256, 2004.
13. Granger J, Siddiqui J, Copeland S, et al. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 5:4713-4718, 2005.
14. Moore RJ, Chamberlain RM, Khuri FR. Apoliproprotein E and the risk of breast cancer in Africa-American and non-hispanic white women - A review. Oncol 66:79-93, 2004.
15. Liotta LA, Petricoin EF. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J Clin Invest 116:26-30, 2006.
16. Hochepied T, Berger F, Bauman H, et al. Alpha1-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytok Growth Factor Rev 14:25-34, 2003.
17. Xiao T, Ying W, Li L, et al. An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics 4:1480-1486, 2005.
18. Tseng CF, Lin CC, Huang HY, et al. Antioxidant role of human haptoglobin. Proteomics 4:2221-2228, 2004.
19. He QY, Lau GKK, Zhou Y, et al. Serum biomarkers of hepatitis B virus infected liver inflammation: A proteomic study. Proteomics 3:666-674, 2003.
20. Thadikkaran L, Siegenthaler M, Crettaz D, et al. Recent advances in blood-related proteomics. Proteomics 5:3019-3034, 2005.
21. Nedelkov D, Kienan UA, Niederkoffer EE, et al. Investigating diversity in human plasma proteins. PNAS 102:10852-10857, 2005.
22. Steel LF, Shumpert D, Trotter M, et al. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma. Proteomics 3:601-609, 2003.
23. Zhang Z, Bast RC, Yu YH, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 64:5882-5890, 2004.
24. Hidalgo A, Baudis M, Petersen I, et al. Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma. BMC Cancer 5:77-83, 2005.
25. Vázquez G, Pina P, Vazquez K, et al. Overexpression of cathepsina F, matriz metalloproteinases 11 y 12 in cervical cancer. Biomed Central 1-19, 2005.
26. Overall CM, Kleifeld O. Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Brit J Cancer,94:941-946, 2006.
27. Lau A, He Q, Chiu J. Proteomic technology and its biomedical application. Acta Biochem Biopy Sinica 35:965-975, 2003.
28. Leeman MF, Curran S, Murray GI. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 201:528-534, 2003.